MTW NHS Trust West Kent CCG

Drug Status Key

  • Preferred
  • Second Line
  • Third Line
  • Specialist Initiation
  • Hospital Only
  • Not Approved for Formulary

Hyperhidrosis

Drug Safety update

 December 2014: Botulinum toxin products: rare but serious risks

Botulinum toxin type A complex is licensed for use intradermally for severe hyperhidrosis of axillae unresponsive to topical antiperspirant and other antihidrotic treatment.